DK1814880T3 - Imidazo[1,2-a]pyridinforbindelser, og sammensætninger, anvendelser og fremgangsmåder, der er forbundet dermed - Google Patents
Imidazo[1,2-a]pyridinforbindelser, og sammensætninger, anvendelser og fremgangsmåder, der er forbundet dermedInfo
- Publication number
- DK1814880T3 DK1814880T3 DK05808135T DK05808135T DK1814880T3 DK 1814880 T3 DK1814880 T3 DK 1814880T3 DK 05808135 T DK05808135 T DK 05808135T DK 05808135 T DK05808135 T DK 05808135T DK 1814880 T3 DK1814880 T3 DK 1814880T3
- Authority
- DK
- Denmark
- Prior art keywords
- imidazo
- compositions
- associated therewith
- pyridine compounds
- methods associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04105698 | 2004-11-11 | ||
PCT/EP2005/055753 WO2006051063A1 (en) | 2004-11-11 | 2005-11-04 | Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1814880T3 true DK1814880T3 (da) | 2009-05-18 |
Family
ID=34929843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05808135T DK1814880T3 (da) | 2004-11-11 | 2005-11-04 | Imidazo[1,2-a]pyridinforbindelser, og sammensætninger, anvendelser og fremgangsmåder, der er forbundet dermed |
Country Status (24)
Country | Link |
---|---|
US (1) | US20080200473A1 (ja) |
EP (1) | EP1814880B1 (ja) |
JP (1) | JP2008519805A (ja) |
KR (1) | KR20070084026A (ja) |
CN (1) | CN101065377B (ja) |
AR (1) | AR051626A1 (ja) |
AT (1) | ATE421962T1 (ja) |
AU (1) | AU2005303811A1 (ja) |
BR (1) | BRPI0517796A (ja) |
CA (1) | CA2585315A1 (ja) |
DE (1) | DE602005012598D1 (ja) |
DK (1) | DK1814880T3 (ja) |
ES (1) | ES2321858T3 (ja) |
IL (1) | IL182963A0 (ja) |
MX (1) | MX2007005611A (ja) |
NO (1) | NO20072831L (ja) |
PA (1) | PA8652101A1 (ja) |
PE (1) | PE20060967A1 (ja) |
PL (1) | PL1814880T3 (ja) |
PT (1) | PT1814880E (ja) |
RU (1) | RU2007121864A (ja) |
TW (1) | TWI357412B (ja) |
UY (1) | UY29204A1 (ja) |
WO (1) | WO2006051063A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2477604A1 (en) | 2002-03-13 | 2003-09-25 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
EP1843734A4 (en) | 2005-02-03 | 2008-09-10 | Signum Biosciences Inc | COMPOSITIONS AND METHOD FOR INTENSIFYING COGNITIVE FUNCTIONS |
US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
EP1845098A1 (en) * | 2006-03-29 | 2007-10-17 | Ferrer Internacional, S.A. | Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands |
AU2007267183B2 (en) * | 2006-05-31 | 2011-10-20 | F. Hoffmann-La Roche Ag | Aryl-4-ethynyl-isoxazole derivatives |
KR20090063220A (ko) * | 2006-08-24 | 2009-06-17 | 오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 | 말초 벤조디아제핀 수용체를 표적화하기 위한 플루오르화된리간드 |
CN102014897B (zh) | 2008-04-21 | 2015-08-05 | 西格纳姆生物科学公司 | 化合物、组合物和其制备方法 |
EP2300470A2 (en) | 2008-05-19 | 2011-03-30 | Sepracor Inc. | Imidazo[1,2-a]pyridine compounds as gaba-a receptor modulators |
WO2010045615A2 (en) | 2008-10-16 | 2010-04-22 | Cenomed Biosciences, Llc | Treatment of organophosphate exposure with ocinaplon |
DK2376490T3 (da) * | 2008-12-04 | 2013-04-15 | Proximagen Ltd | Imidazopyridinforbindelser |
CN110483499A (zh) * | 2009-11-05 | 2019-11-22 | 圣母大学 | 咪唑并[1,2-a]吡啶类化合物及其合成及使用方法 |
US8729271B2 (en) | 2010-09-17 | 2014-05-20 | Taisho Pharmaceutical Co., Ltd | Glycine transporter inhibiting substances |
PE20181352A1 (es) | 2015-09-17 | 2018-08-22 | Marvin J Miller | Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias |
CN106906486B (zh) * | 2017-02-22 | 2018-12-11 | 华南理工大学 | 3-溴-2-苯基-咪唑并[1,2-α]吡啶类衍生物的电化学合成方法 |
US20230121497A1 (en) * | 2020-01-29 | 2023-04-20 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2568880B1 (fr) * | 1984-08-07 | 1986-12-12 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique |
EP0234970B1 (fr) * | 1986-01-22 | 1991-04-17 | Synthelabo | Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique |
FR2593818B1 (fr) * | 1986-02-05 | 1988-04-29 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique |
FR2593181B1 (fr) * | 1986-01-22 | 1988-04-01 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique |
WO2004066930A2 (en) * | 2003-01-27 | 2004-08-12 | Arthur Zaks | Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives |
-
2005
- 2005-11-04 EP EP05808135A patent/EP1814880B1/en not_active Not-in-force
- 2005-11-04 JP JP2007540634A patent/JP2008519805A/ja active Pending
- 2005-11-04 KR KR1020077010318A patent/KR20070084026A/ko not_active Application Discontinuation
- 2005-11-04 AU AU2005303811A patent/AU2005303811A1/en not_active Abandoned
- 2005-11-04 PT PT05808135T patent/PT1814880E/pt unknown
- 2005-11-04 AT AT05808135T patent/ATE421962T1/de active
- 2005-11-04 WO PCT/EP2005/055753 patent/WO2006051063A1/en active Application Filing
- 2005-11-04 DK DK05808135T patent/DK1814880T3/da active
- 2005-11-04 CN CN2005800386913A patent/CN101065377B/zh not_active Expired - Fee Related
- 2005-11-04 PL PL05808135T patent/PL1814880T3/pl unknown
- 2005-11-04 ES ES05808135T patent/ES2321858T3/es active Active
- 2005-11-04 MX MX2007005611A patent/MX2007005611A/es active IP Right Grant
- 2005-11-04 US US11/667,494 patent/US20080200473A1/en not_active Abandoned
- 2005-11-04 DE DE602005012598T patent/DE602005012598D1/de active Active
- 2005-11-04 CA CA002585315A patent/CA2585315A1/en not_active Abandoned
- 2005-11-04 BR BRPI0517796-0A patent/BRPI0517796A/pt not_active IP Right Cessation
- 2005-11-04 RU RU2007121864/04A patent/RU2007121864A/ru not_active Application Discontinuation
- 2005-11-07 PE PE2005001302A patent/PE20060967A1/es not_active Application Discontinuation
- 2005-11-08 PA PA20058652101A patent/PA8652101A1/es unknown
- 2005-11-08 TW TW094139042A patent/TWI357412B/zh not_active IP Right Cessation
- 2005-11-09 AR ARP050104693A patent/AR051626A1/es not_active Application Discontinuation
- 2005-11-10 UY UY29204A patent/UY29204A1/es not_active Application Discontinuation
-
2007
- 2007-05-03 IL IL182963A patent/IL182963A0/en unknown
- 2007-06-04 NO NO20072831A patent/NO20072831L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1814880A1 (en) | 2007-08-08 |
KR20070084026A (ko) | 2007-08-24 |
CA2585315A1 (en) | 2006-05-18 |
PT1814880E (pt) | 2009-04-23 |
TW200624432A (en) | 2006-07-16 |
NO20072831L (no) | 2007-08-01 |
CN101065377A (zh) | 2007-10-31 |
US20080200473A1 (en) | 2008-08-21 |
AR051626A1 (es) | 2007-01-24 |
MX2007005611A (es) | 2007-07-11 |
PE20060967A1 (es) | 2006-09-20 |
UY29204A1 (es) | 2006-01-31 |
TWI357412B (en) | 2012-02-01 |
PL1814880T3 (pl) | 2009-07-31 |
IL182963A0 (en) | 2007-08-19 |
RU2007121864A (ru) | 2008-12-20 |
AU2005303811A1 (en) | 2006-05-18 |
PA8652101A1 (es) | 2006-10-13 |
CN101065377B (zh) | 2011-07-27 |
ES2321858T3 (es) | 2009-06-12 |
BRPI0517796A (pt) | 2008-10-28 |
DE602005012598D1 (de) | 2009-03-19 |
ATE421962T1 (de) | 2009-02-15 |
JP2008519805A (ja) | 2008-06-12 |
WO2006051063A1 (en) | 2006-05-18 |
EP1814880B1 (en) | 2009-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1814880T3 (da) | Imidazo[1,2-a]pyridinforbindelser, og sammensætninger, anvendelser og fremgangsmåder, der er forbundet dermed | |
IS2795B (is) | Pýrasóló[3,4-b]pýridín efnasambönd, og notkun þeirra sem fosfórdíesterasa hindrar | |
HK1118284A1 (en) | Imidazo [1,2-a]pyridine compounds as vegf-r2 inhibitors | |
DK1966202T3 (da) | Heteroarylsubstituerede pyrrolo[2,3-b]pyridiner og pyrrolo[2,3-d]pyrimidiner som Januskinaseinhibitorer | |
EP1741703A4 (en) | PYRIDONE DERIVATIVE | |
ZA200802497B (en) | Imidazo [1,2-A] pyridine having anti-cell-proliferation actvity | |
ZA200703912B (en) | 3-arylamino pyridine derivatives | |
IL180430A0 (en) | Pyridine derivatives | |
BRPI0822237A2 (pt) | Compostos de imidazo [1,2-a] piridina | |
ZA201202025B (en) | INTERMEDIATES USEFUL IN THE PREPARATION OF PYRROLO[2,3-b] PYRIDINE DERIVATIVES | |
DK1761542T3 (da) | Octahydropyrrolo[3,4-C] pyrrolderivater og anvendelsen deraf som antivirusmidler | |
HK1103730A1 (en) | Pyrrolopyridine derivatives and their use as crth2antagonists | |
NO20054330D0 (no) | 8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater | |
EP1820797A4 (en) | SUBSTITUTED PYRIDONE DERIVATIVE | |
NO20054331D0 (no) | Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater | |
IL201009A (en) | Pyrazolo pyridine derivatives, preparations containing them and their uses | |
ZA200805354B (en) | Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives | |
IL179605A0 (en) | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists | |
AU2003255323A8 (en) | Imidazo`1,2-a pyridines | |
DK1899343T3 (da) | Halogenerede pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelser som GABA-A-receptorligand, sammensætninger og mellemprodukter | |
NL1033403A1 (nl) | Therapeutische pyrazolo[3,4-b]pyridinen en indazolen. | |
DK1957490T3 (da) | Hidtil ukendte indolizinderivater, fremgangsmåde til fremstilling deraf og terapeutiske sammensætninger, der omfatter samme | |
DK2059521T3 (da) | Pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelse og sammensætninger | |
ZA200802824B (en) | Methods of 1 H-imidazo[4,5-c]pyridines and analogs thereof | |
GB0416524D0 (en) | Pyridine derivatives |